US healthcare giant Johnson & Johnson will buy Swiss bio-tech company Actelion in a $30 billion all-cash deal that includes spinning off Actelion's research and development pipeline, the co-mpanies said on Thursday. The acquisition gives J&J access to the ... The Financial Chronicle, 1 month ago
By Silke Koltrowitz ZURICH (Reuters) - Three years ago, Swatch Group was riding high. The world's largest watchmaker, known for its colourful plastic watches as well as upscale brands including Breguet, reported record gross sales. Then in several newspaper ...Sify, 2 months ago
on your WebpageAdd Widget >Get your members hooked!